1.

Record Nr.

UNINA9910563070203321

Autore

Kakridis Ioannis

Titolo

Codex 88 des Klosters Dečani und seine griechischen Vorlagen : Ein Kapitel der serbisch-byzantinischen Literaturbeziehungen im 14. Jahrhundert / Ioannis Kakridis

Pubbl/distr/stampa

Frankfurt a.M, : PH02, 1988

Edizione

[1st, New ed.]

Descrizione fisica

1 online resource (362 p.) : , EPDF

Collana

Slavistische Beiträge ; 233

Soggetti

Literature & literary studies

Lingua di pubblicazione

Tedesco

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Peter Lang GmbH, Internationaler Verlag der Wissenschaften

Nota di contenuto

Einleitung - Benutzungshinweis - Die handschriftliche Überlieferung - Die restlichen Texte in Dečani - Die Scholien zu den Traktaten von Dečani - Cod. 88 des Klosters Dečani als serbisch-kirchenslavisches Sprachdenkmal des 14. Jahrhunderts - Zur Übersetzungstechnik in den theologischen Traktaten von Dečani - Die Areopagitazitate in den Traktaten von Dečani - Das Rätsel der Übersetzungen von Dečani

Sommario/riassunto

Ziel vorliegender Untersuchung ist es, der wissenschaftlichen Erforschung eines der interessantesten serbisch-kirchenslavischen Sprachdenkmäler des 14. Jahrhunderts, cod. 88 der Bibliothek des Klosters Dečani, den Weg zu ebnen. Summary in Serbian.



2.

Record Nr.

UNINA9910963416303321

Titolo

Building a national framework for the establishment of regulatory science for drug development : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs

Pubbl/distr/stampa

Washington, D.C., : National Academies Press, 2011

ISBN

0-309-20959-5

1-283-01910-8

9786613019103

0-309-15890-7

Edizione

[First edition.]

Descrizione fisica

1 online resource (95 pages)

Altri autori (Persone)

LebovitzYeonwoo

EnglishRebecca A

ClaiborneAnne B

Disciplina

615.1

Soggetti

Pharmaceutical policy - United States

Drug development - Government policy - United States

Pharmaceutical industry - Government policy - United States

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

"Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy."

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""Preface""; ""1 Introduction""; ""2 Defining Regulatory Science""; ""3 The Urgent Need for Regulatory Science""; ""4 Barriers to Enhanced Regulatory Science""; ""5 Potential Models for Building a Regulatory Science Infrastructure""; ""6 Challenges in Engaging the Public Policy Community""; ""7 Envisioning Successful Regulatory Science at FDA""; ""8 Considering Next Steps""; ""References""; ""Appendix A: Agenda""; ""Appendix B: Participant Biographies""

Sommario/riassunto

"The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to



consider approaches for enhancing it."--Publisher's description.